Tracking baby health: lupus drug pregnancy registry launches
NCT ID NCT06659029
Summary
This study is collecting information about pregnancy outcomes in women with moderate to severe lupus who take the medication anifrolumab. Researchers will compare health results for mothers and babies exposed to the drug during pregnancy against those who used other lupus treatments. The goal is to understand the safety of this medication for pregnant women and their infants through careful observation of medical records.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGWilmington, North Carolina, 28401, United States
Conditions
Explore the condition pages connected to this study.